Effect of alginate size, mannuronic/guluronic acid (cas 15769-56-9) content and pH on particle size, thermodynamics and composition of complexes with β-lactoglobulin
-
Add time:09/10/2019 Source:sciencedirect.com
Alginate is an anionic polysaccharide capable of forming insoluble particles with proteins. Hence, alginate has potential as a protein carrier. However, the role of physical properties of the polysaccharide, such as degree of polymerization (DPn) and mannuronic/guluronic acid ratio, remains to be fully explored. Particle formation of a high and a low molar mass alginate (ALG) with β-lactoglobulin (BLG) at pH 2–8 depends on the average DPn (HMW-ALG: 1.59·103; LMW-ALG: 0.23·103) and the mannuronic/guluronic acid ratio (1.0; 0.6) as supported by using ManA6 and GulA6 as models. Dynamic light scattering (DLS) showed that particles of BLG with either of the two ALGs have essentially the same hydrodynamic diameter (DH) at pH 3 and 2, while at pH 4 particles of LMW-ALG/BLG have larger DH than of HMW-ALG/BLG. At pH 5–8 no significant particle formation was observed. ManA6 did not form insoluble particles at pH 2–8, while GulA6 formed insoluble particles, albeit only at pH 4. Kd was approximately 10-fold higher for LMW-ALG/BLG than HMW-ALG/BLG and 3 orders of magnitude higher for an alginate trisaccharide/BLG complexation as determined by isothermal titration calorimetry (ITC). The alginate trisaccharide did not form insoluble particles with BLG at pH 3 and 4, though interaction still occurred. ΔHapp and molar stoichiometry of BLG in the complexes with the two ALGs differed by a factor of 7, as did their DPn, which thus affected the interaction strength, but not the BLG content. At pH 4 the BLG content doubled in the particle due to BLG dimerization. The findings emphasize the importance of DPn, mannuronic/guluronic acid ratio and pH in formulations containing alginate/whey protein particles.
We also recommend Trading Suppliers and Manufacturers of guluronic acid (cas 15769-56-9). Pls Click Website Link as below: cas 15769-56-9 suppliers
Prev:Physicochemical properties of alginate-based films: Effect of ionic crosslinking and mannuronic and guluronic acid (cas 15769-56-9) ratio
Next:Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (cas 15769-56-9) (G2013) on cancer-related inflammation in a murine breast cancer model) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyNanoparticulate Assembly of Mannuronic Acid-and guluronic acid (cas 15769-56-9)-Rich Alginate: Oral Insulin Carrier and Glucose Binder09/27/2019
- Preparation and characterization of guluronic acid (cas 15769-56-9) oligosaccharides degraded by a rapid microwave irradiation method09/26/2019
- An in vitro evaluation of anti-aging effect of guluronic acid (cas 15769-56-9) (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs09/25/2019
- Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (cas 15769-56-9) (G2013) on cancer-related inflammation in a murine breast cancer model09/24/2019
- Physicochemical properties of alginate-based films: Effect of ionic crosslinking and mannuronic and guluronic acid (cas 15769-56-9) ratio09/09/2019
- Impact of hydrolysis conditions on the detection of mannuronic to guluronic acid (cas 15769-56-9) ratio in alginate and its derivatives09/08/2019
- Effects of guluronic acid (cas 15769-56-9) (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway09/07/2019
- The alginate lyase from Isoptericola halotolerans CGMCC 5336 as a new tool for the production of alginate oligosaccharides with guluronic acid (cas 15769-56-9) as reducing end09/06/2019
- Original articleThe safety and efficacy of guluronic acid (cas 15769-56-9) (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial09/05/2019
-
Health and Chemical more >


